Recursion Pharmaceuticals, Inc. Class A Common Stock Share Price
NASDAQ: RXRXHealthcare
Live Recursion Pharmaceuticals, Inc. Class A Common Stock Share Price Chart
O H L
Recursion Pharmaceuticals, Inc. Class A Common Stock Performance Overview
Days Range
▼
$3.51Low
$3.60High
Markets Today
| Previous Close | $3.54 |
|---|---|
| Open | $3.55 |
| Volume | 2,565,614 |
| Day's Range | $3.51 - $3.60 |
| 52W Range | $2.77 - $7.18 |
| Market Cap | $1.71 B |
Historical Performance
| 1M Returns | +14.56 |
|---|---|
| 3M Returns | +9.60 |
| 6M Returns | +6.63 |
| 1Y Returns | -28.19 |
| 5Y Returns | -86.80 |
| 10Y Returns | NA |
Recursion Pharmaceuticals, Inc. Class A Common Stock Fundamentals
| Market Cap | $1.71 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $74.68 M |
| ROE TTM | -0.60 |
| EPS TTM | $-1.04 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 1.86 |
| EBITDA | $-564.43 M |
| Profit Margin | -863.35 |
| Market Cap | $1.71 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $74.68 M |
| ROE TTM | -0.60 |
| EPS TTM | $-1.04 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 1.86 |
| EBITDA | $-564.43 M |
| Profit Margin | -863.35 |
Recursion Pharmaceuticals, Inc. Class A Common Stock Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $14.74 M | $19.22 M | $5.17 M | $35.54 M | $6.47 M | $7.67 M |
| Gross Profit + | -$7.08 M | -$938.00 K | -$9.51 M | $21.26 M | -$6.02 M | -$3.82 M |
| Operating Income | -$191.37 M | -$176.23 M | -$172.20 M | -$108.33 M | -$128.50 M | -$134.97 M |
| EBITDA | -$172.04 M | -$152.38 M | -$151.16 M | -$88.86 M | -$108.83 M | -$116.80 M |
| Interest Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Depreciation | $19.33 M | $23.85 M | $21.04 M | $19.48 M | $19.67 M | $18.17 M |
| Income Before Tax | -$202.65 M | -$171.90 M | -$162.25 M | -$108.10 M | -$122.11 M | -$131.01 M |
| Income Tax Expense | -$158.00 K | $0 | $3.00 K | $20.00 K | -$4.60 M | -$1.00 K |
| Net Income + | -$202.49 M | -$171.90 M | -$162.25 M | -$108.12 M | -$117.50 M | -$131.00 M |
| Net Profit Margin | -1373.26% | -894.23% | -3135.32% | -304.24% | -1815.57% | -1708.02% |
Recursion Pharmaceuticals, Inc. Class A Common Stock Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $4.00 K | $4.00 K | $5.00 K | $5.00 K | $5.00 K | $5.00 K |
| Reserve & Surplus | -$1.62 B | -$1.76 B | -$1.93 B | -$2.04 B | -$2.17 B | -$2.30 B |
| Non-Current Liabilities | $229.31 M | $219.18 M | $197.47 M | $195.56 M | $185.05 M | $177.78 M |
| Current Liabilities | $141.98 M | $164.03 M | $155.10 M | $147.71 M | $129.70 M | $119.89 M |
| Total Liabilities | $371.29 M | $383.21 M | $352.58 M | $343.26 M | $314.75 M | $297.67 M |
| Fixed Assets | $462.62 M | $461.36 M | $434.05 M | $413.83 M | $389.88 M | $372.51 M |
| Current Assets | $584.14 M | $587.16 M | $714.11 M | $812.85 M | $709.56 M | $603.46 M |
| Total Assets | $1.31 B | $1.30 B | $1.40 B | $1.47 B | $1.34 B | $1.21 B |
Recursion Pharmaceuticals, Inc. Class A Common Stock Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$202.49 M | -$171.90 M | -$162.25 M | -$108.12 M | -$117.50 M | -$131.00 M |
| Operating Cash Flow | -$131.96 M | -$76.42 M | -$117.36 M | -$46.07 M | -$81.10 M | -$105.95 M |
| Investing Cash Flow | -$7.27 M | -$5.81 M | $451.00 K | -$1.24 M | -$338.00 K | -$1.96 M |
| Financing Cash Flow | $40.53 M | $97.66 M | $248.34 M | $132.01 M | -$3.47 M | -$1.27 M |
| Change in Cash | -$93.87 M | $24.69 M | $133.30 M | $86.78 M | -$88.74 M | -$108.36 M |
Recursion Pharmaceuticals, Inc. Class A Common Stock Peer Comparison
| Company | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|
 | $5.05B | -53.96% | 0.00 | -16569.77% | 0.00% |
Recursion Pharmaceuticals, Inc. Class A Common Stock Return Calculator
The Recursion Pharmaceuticals, Inc. Class A Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$1,317
Invested Amount$10,000
Est. Returns$-8,683
About Recursion Pharmaceuticals, Inc. Class A Common Stock
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States.
Popular Stocks
FAQs
What is the share price of Recursion Pharmaceuticals, Inc. Class A Common Stock today?
Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX) share price as of September 18, 2026 is $3.53. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Recursion Pharmaceuticals, Inc. Class A Common Stock?
Yes, Indian Investors can invest in the Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX) Share by opening an international trading account with Angel One.
How can I purchase Recursion Pharmaceuticals, Inc. Class A Common Stock shares in India?
Purchasing Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Recursion Pharmaceuticals, Inc. Class A Common Stock?
Yes, you can purchase fractional shares of Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Recursion Pharmaceuticals, Inc. Class A Common Stock?
The market capitalization of Recursion Pharmaceuticals, Inc. Class A Common Stock on September 18, 2026, is $1.71 B.
In which sector Recursion Pharmaceuticals, Inc. Class A Common Stock belongs?
Recursion Pharmaceuticals, Inc. Class A Common Stock operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Recursion Pharmaceuticals, Inc. Class A Common Stock stocks?
In order to invest in Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
